SEBIA

Sebia, founded in 1967, is a global leader in clinical electrophoresis technology and in-vitro diagnostic manufacturing. The company specializes in advanced equipment and reagents designed for high-precision protein analysis. By providing innovative systems for laboratory screening and monitoring, Sebia supports healthcare professionals in the detection and management of complex medical conditions. Their diagnostic solutions are critical in oncology, particularly for multiple myeloma, as well as in identifying metabolic disorders and various hemoglobinopathies.

Operating with a workforce of 1,000-5,000 employees across 4 global locations, Sebia maintains a robust operational footprint. The organization emphasizes quality management systems and cutting-edge scientific expertise to ensure reliable diagnostic outcomes. Meet Sebia's team to learn about their leadership and the organizational structure driving their technological advancements. The company’s commitment to innovation ensures that its diagnostic kits and separation technologies remain at the forefront of clinical diagnostics, facilitating early disease detection and improved patient care pathways worldwide.

In the competitive landscape of test and measurement equipment, Sebia positions itself against major industry players such as Bio-Rad Laboratories, SCIEX, and Beckman Coulter Diagnostics. By focusing on specialized clinical diagnostics, the company addresses critical needs in genetic and metabolic testing. Sebia’s strategic focus on B2B and B2C markets, combined with its long-standing history in the manufacturing sector, reinforces its market presence. The company continues to leverage its expertise to deliver high-quality diagnostic tools that meet the evolving demands of modern healthcare systems globally.